Wisderm.com
Open menu
Concerns
Interventions
Latest Research
FAQ
Ingestion of a collagen peptide containing high concentrations of prolyl-hydroxyproline and hydroxyprolyl-glycine reduces advanced glycation end products levels in the skin and subcutaneous blood vessel walls: a randomized, double-blind, placebo-controlled study
Study Design
Subject Type
Human
Trial Design
Double-Blind, Randomised, Controlled
Trial Duration
84 days
Participants
31 (30 completed)
Age Range
47-87 years
Mechanisms
Intervention(s)
Outcome
Method
Effect
Description
Collagen Supplement
Glycation
AGE Reader
🠫
Sign in to read for free
Sign in to read for free
Study Summary
Sign in to read for free